Psychedelics Therapeutics Development and Trends, 2024

This report provides a summary of the current and future state of the psychedelic therapeutic sector, offering a high-level analysis of key trends and developments within the industry, including regulatory, clinical, and market dynamics. The report identifies the broader changes within the evolving psychedelic industry, facilitating informed decision-making for relevant sectors.

Scope

This 36-page report gives important, expert insight you won’t find in any other source. 12 figures throughout the report illustrate major points and trends in future pharmaceutical sales forecasts and company pipelines. This report is required reading for :

• Investors that want to understand future trends impacting the psychedelic drug industry as well as identifying companies to invest in
• Companies that are interested in entering the psychedelic drug industry and where best to focus on
• Large pharma companies with investment groups or BD teams looking to see which companies are predicted to lead the industry in the near and far future
• Small and medium pharma who want to focus their drug portfolio on future trends and are looking for partnership opportunities

Reasons to Buy

• Insights on psychedelic drugs by development stage
• Insights on dealmaking trends
• Insights on psychedelic drugs clinical trial trends
• Insights on psychedelic drugs review designations awarded over time
• Insights on leading psychedelic companies and sponsors
• Therapeutic and Indication insights into the psychedelic drug market